Compulsory licence likely for three cancer drugs

By DIVYA RAJAGOPAL MUMBAI: The government has appointed a panel to look into issues related to compulsory licensing of drugs and whether cheaper versions of cancer medicines Trastuzumab, ...

EU agency sees no new risks with combined contraceptives

(Reuters) – European drug regulators said on Friday there was no reason for women to stop using combined contraceptives like Bayer’s Meliane or Yasmin pills since there ...

FDA Does About Face On Research Misconduct Rule

By Ed Silverman Last summer, the FDA proposed a new rule designed to tighten the dissemination of information related to investigations into research misconduct by individuals, including ...
© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS